Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Critical Care
•
Hospital Medicine
•
General Hospital Medicine
How do you think about deferring VTE prophylaxis versus implementing pharmacologic methods when chemical prophylaxis is contraindicated?
Related Questions
How do you decide whether to use lung POCUS versus CT as the next step when a chest X-ray is equivocal for pneumonia?
What is your approach to electrolyte repletion for patients hospitalized with non-cardiac conditions?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
Do you prefer scopolamine patches, glycopyrrolate, or other treatment regimens to manage oral secretions at the end of life?
What is your preferred first-line agent for VTE prophylaxis in hospitalized medical patients with adequate renal function?
At what point should you consider deactivating ICDs or implanted pacemakers in patients nearing the end of life but not imminently dying?
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
How do you use cardiac POCUS to potentially defer formal echocardiogram in patients presenting with an acute pulmonary embolism?
What do you think about starting octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
